Particle.news

Download on the App Store

Smoked and Edible Cannabis Use Impairs Vascular Health, Study Finds

Impaired endothelial function linked to cannabis use raises cardiovascular event risk, highlighting need for long-term research.

Employees inspect cannabis plants at cannabis grower Hollandse Hoogtes, where regulated cannabis cultivation takes place in a grow center, in Bemmel, Netherlands, on April 1, 2025.
Image
Sunnyside Chews cannabis edible gummies at a Cresco Labs Inc. facility in Indiantown, Florida, U.S., on Monday, March 28, 2022. A bright spot in the beleaguered legal-cannabis industry may be U.S. multistate operators, which we expect to lead the group's 1Q year-over-year sales growth, largely reflecting their expansion in U.S. state-legal markets. Photographer: Eva Marie Uzcategui/Bloomberg via Getty Images
Photo - Canva

Overview

  • A JAMA Cardiology study of 55 otherwise healthy adults found regular marijuana smokers had a 42% reduction in vascular function and THC-edible users a 56% reduction compared to nonusers.
  • Serum from marijuana smokers reduced nitric oxide production in cultured endothelial cells by 27%, whereas THC-edible users’ serum showed no such effect.
  • Higher frequency and potency of cannabis consumption correlated with greater endothelial dysfunction, indicating a dose-dependent relationship.
  • Previous analyses of over 4.6 million adults under age 50 linked cannabis use to up to a sixfold higher risk of heart attack and a fourfold increase in ischemic stroke.
  • Researchers urge clinicians to include cannabis use in cardiovascular risk assessments and call for larger, long-term studies to determine safe usage levels.